Accessibility Menu
 

Polyrizon

(NASDAQ) PLRZ

Current Price$11.86
Market Cap$17.97M
Since IPO (2024)-100%
5 YearN/A
1 Year-98%
1 Month-15%

Polyrizon Financials at a Glance

Market Cap

$17.97M

Revenue (TTM)

$0.00

Net Income (TTM)

$4.12M

EPS (TTM)

$-2.70

P/E Ratio

-4.10

Dividend

$0.00

Beta (Volatility)

-1.08 (Low)

Price

$11.86

Volume

0

Open

$11.00

Previous Close

$11.86

Daily Range

$11.00 - $11.89

52-Week Range

$2.88 - $2235.00

PLRZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Polyrizon

Industry

Biotechnology

Employees

6

CEO

Tomer Izraeli, MBA

Headquarters

Ra'anana, 4366507, IL

PLRZ Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-25%

Return on Capital

-18%

Return on Assets

-19%

Earnings Yield

-24.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.97M

Shares Outstanding

1.62M

Volume

0

Short Interest

0.00%

Avg. Volume

56.98K

Financials (TTM)

Gross Profit

$342.00K

Operating Income

$6.25M

EBITDA

$5.91M

Operating Cash Flow

$4.53M

Capital Expenditure

$7.00K

Free Cash Flow

$4.54M

Cash & ST Invst.

$12.27M

Total Debt

$0.00

Polyrizon Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$153.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$17.97M

N/A

Market Cap/Employee

$8.99M

N/A

Employees

2

N/A

Net Income

$3.16M

-659879.1%

EBITDA

$3.61M

-861713.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$12.27M

+380.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-19.20%

N/A

Return on Invested Capital

-17.91%

N/A

Free Cash Flow

$2.71M

-669529.6%

Operating Cash Flow

$2.71M

-668295.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics, Inc.
$3.48-16.14%
VYNEVYNE Therapeutics Inc.
$0.59-1.77%
TCRTAlaunos Therapeutics, Inc.
$2.92+1.74%
KTTAPasithea Therapeutics Corp.
$0.80+0.62%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$44.15+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.49-0.03%
AALAmerican Airlines Group
$10.81-0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$75.91-0.00%

Questions About PLRZ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.